ANDA 79086, held by Petnet. Fludeoxyglucose F-18.
As of Nov 16, 2026, ANDA 79086 (Fludeoxyglucose F18), held by Petnet, was first approved by FDA on Feb 25, 2011, with 3 approved supplements and 0 published complete response letters.
Fludeoxyglucose F 18 Injection is indicated for positron emission tomography (PET) imaging in the following settings:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 25, 2011 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fludeoxyglucose F1820-200mCi/ML · injectable;intravenous | Fludeoxyglucose F-18 | Rx |
| Aug 31, 2026 | Supplement 31Manufacturing | Approved | None posted |
| Jan 3, 2020 | Supplement 21Labeling · Standard review | Approved | None posted |
| Oct 27, 2011 | Supplement 4Labeling | Approved | None posted |
| Feb 25, 2011 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters